Hector has written for:

Pfizer, Sanofi, Syngenta, Lilly, AstraZeneca, Vertex, Novartis, Roche, CRISPR Therapeutics, Astellas, Bayer, Chugai, Gilead, the NHS

Clear and engaging communication of scientific research is essential to build public support, attract investment, and motivate R&D colleagues. Few writers can both understand the complexities of advanced science and describe it in terms comprehensible and interesting to a lay audience.

Hector has drawn on a first class biology degree from the University of Oxford, extensive consulting experience in Life Sciences and his career as a bestselling author to build a distinguished reputation as a science writer.

He was the researcher and ghost writer for a well-reviewed book about pharmaceutical drug development. Over the course of three years, he interviewed more than one hundred scientists at eight Pharma companies in order to write the in-depth stories of their discoveries.

Hector has also written dozens of shorter accounts of scientific achievement for Life Sciences companies.